Physician profile
Harshadkumar Patel
NPI 1205332673
$14,366.94
in general payments reported to CMS, 2019-2025
23 companies · $1,246 in 2025
The $1,246 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,887 · 2022: $5,445 · 2023: $1,782 · 2024: $2,007 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,034.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $5,445.72 | 2021-2023 | |
| Globus Medical, INC. | $4,189.10 | 2022-2025 | Reline, Excelsiusgps Robotic Navigation System, Tlif |
| Stryker Corporation | $1,461.05 | 2021-2023 | Cascadia Interbody System |
| Medtronic, INC. | $432.90 | 2022 | |
| Orthofix Medical, INC. | $322.08 | 2022-2023 | Spinal-Stim, Cervical-Stim |
| Si-Bone, INC. | $313.71 | 2023-2025 | |
| Djo, LLC | $226.52 | 2024-2025 | Cmf |
| Providence Medical Technology, INC. | $213.89 | 2024 | |
| Centinel Spine, LLC | $186.75 | 2022 | |
| Clariance, INC. | $173.37 | 2023 | Erisma-LP |
| Cerapedics INC. | $165.69 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Amgen INC. | $148.74 | 2025 | |
| Alafair Biosciences, INC. | $148.14 | 2023 | Versawrap |
| Smith+Nephew, INC. | $146.75 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Icotec Medical INC. | $144.29 | 2023 | Icotec Blackarmor Spine System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $137.01 | 2022 | |
| Orthopediatrics Corp. | $134.10 | 2022-2023 | |
| Heron Therapeutics, INC. | $122.47 | 2022 | |
| Nevro Corp. | $106.13 | 2023 | Senza |
| Spineology INC. | $72.12 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $39.47 | 2023 | Uzedy, Austedo Xr |
| Augmedics INC. | $20.24 | 2024 | Xvision |
| Ethicon US, LLC | $16.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshadkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.